Pediatr. praxi. 2008;9(5):282-284

CHILDHOOD ONSET SCHIZOPHRENIA AND SCHIZOPHRENIA IN ADOLESCENTS

doc. MUDr. Eva Malá CSc
Psychiatrická ambulance, Neurologická klinika 1. LF UK a VFN, Praha

Schizophrenia is a neurodevelopmental disorder. Generalized cognitive deficits increas risk of developing schizophrenia at high risk children. In the article there are considered the important symptoms of childhood onset schizophrenia and schizophrenia in adolescents (prenatal complications, prodromal symptoms, cognitive impairment, suicidal behavior, prognosis, familial impact of schizophrenia). The approved for children pharmacotherapy is generally considered not to be sufficient.

Keywords: Key words: childhood schizophrenia, prodromal symptoms, familiar risk.

Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malá E. CHILDHOOD ONSET SCHIZOPHRENIA AND SCHIZOPHRENIA IN ADOLESCENTS. Pediatr. praxi. 2008;9(5):282-284.
Download citation

References

  1. Asarnow RF, Nuechterlein KH, Asamen J et al. Neurocognitive functioning and schizophrenia spectrum disorders can be independent expressions of familial liability for schizophrenia in community control children: the UCLA family study. Schizophr Res 200; 254(1-2): 111-120.
  2. Bleuler M. The treatment of psychosis of the schizophrenic and manic-depressive type. Stuttgart: Schauttauer 1978.
  3. Eastvold AD, Heaton RK, Cadenhead KS. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res 2007; 93(1-3): 266-277. Go to original source... Go to PubMed...
  4. Faragian S. Kurs R. Poyurovsky M. Insight into obsessive-compulsive symptoms and awareness of illness in adolescent schizophrenia patients with and without OCD. Child Psychiatry Hum Dev 2008; 39(1): 39-48. Go to original source... Go to PubMed...
  5. Hollis C. Developmental precursors of child and adolescent-onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions. Br J Psychiatry 2003; 182: 37-44. Go to original source... Go to PubMed...
  6. Lieberman JA. Malaspina D. Jarskog LF. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection. Schizophr Res 2007; 93(1-3): 266-277.
  7. Malá E. Schizofrenie v dětství a adolescenci. Praha: Grada 2005.
  8. McEvoy JP, Lieberman JA, Perkins DO, Hamer RM, Gu H et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 2007; 164(7): 1050-1060. Go to original source... Go to PubMed...
  9. Murény KC. Schizophrenia and velo-cardio-facial syndrome. Lancet 2002; 359(9304): 426-430. Go to original source... Go to PubMed...
  10. Pasamanick B, Rogers M, Lilienfeld AM. Pregnancy experience and the developmental of childhood behavior disorder. Amer J Psychiat 1956; 12: 614. Go to original source... Go to PubMed...
  11. Pollack M. Werner M. Pre and perinatal complication and childhood schizophrenia. J Child Psychol Psychiat 1966;7: 235. Go to original source... Go to PubMed...
  12. Schwartz O, Apter A, Zalsman G. Depression, suicidal behavior and insight in adolescents with schizophrenia. Eur Child Adolesc Psychiatry 2006; 15(6): 352-359. Go to original source... Go to PubMed...
  13. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait. Arch Gen Psychiatry 2003; 60: 1187-1192. Go to original source... Go to PubMed...
  14. Usiskin et al. Velocardiofacial syndrome in childhood onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1999; 38(12): 1536-1534. Go to original source... Go to PubMed...
  15. Wiesel FA. Schizophrenia is a systemic disease. Genetic mechanisms and environmental factors interact in the disease development. Lakartidningen 2007; 104(30-31): 2146-2147. Go to PubMed...
  16. Wykes T, Newton E. Landau S, et al. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res 2007; 94(1-3): 221-230. Go to original source... Go to PubMed...
  17. Zvolský P. Rozvoj genetiky v psychiatrii. Praha: Avicenum 1990.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.